Last checked at 23 Dec 2019 15:15
Craneware plc
("Craneware", "the Group" or the "Company")
Director's Exercise of Options and Total Voting Rights
23 December 2019 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that Keith Neilson, CEO of the Company, has exercised options over 10,332 ordinary shares of 1p each ("Ordinary Shares") at an exercise price of 335 pence per Ordinary Share.
Following the exercise of these options, Mr Neilson holds 3,397,506 Ordinary Shares in the capital of the Company, representing 12.7 per cent. of the Company's issued share capital. Following completion and settlement of all taxation matters relating to this exercise, Mr Neilson intends to transfer these shares to the Neilson Family Foundation, a charity trust set up for the future benefit of medical research and Young People's charities.
Following this exercise and the exercise of options by another employee, the Company's issued share capital will comprise 26,826,539 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. This figure of 26,826,539 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Financial Conduct Authority's Disclosure and Transparency Rules.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities/person closely associated
| ||
a) | Name: | Keith Neilson
| |
2 | Reason for the notification
| ||
a) | Position/Status:
| Chief Executive Officer | |
b) | Initial Notification/Amendment:
| Initial Notification | |
3 | Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor
| ||
a) | Name: | Craneware plc
| |
b) | LEI: | 213800O2CTJ1YFXNXG05
| |
4. | Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.
| ||
a) | Description of the financial instrument: Identification code: | Ordinary Shares ISIN GB00B2425G68
| |
b) | Nature of the transaction:
| Exercise of options over Ordinary Shares
| |
c) | Price(s) and volume(s): | £3.35 | 10,332 |
d) | Aggregated price(s) and volume(s): | £3.35 | 10,332 |
e) | Date of the Transaction:
| 20 December 2019 | |
f) | Place of the Transaction: | Outside of a trading venue | |
For further information, please contact:
Craneware plc | Peel Hunt | Investec Bank | Alma |
(NOMAD & Joint Broker) | (Joint Broker) | (Financial PR) | |
+44 (0)131 550 3100 | +44 (0)20 7418 8900 | +44 (0)20 7597 5970 | +44 (0)203 405 0205 |
Keith Neilson, CEO | Dan Webster | Patrick Robb | Caroline Forde |
Craig Preston, CFO | George Sellar | Sebastian Lawrence | Hilary Buchanan |
Guy Pengelley | Henry Reast | Helena Bogle |
About Craneware
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.